Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-22

Clinical Trial Update: Renal Impairment Study With ASP1941 [Phase 1]

View source ↗

Summary

Phase 1 renal impairment study of ASP1941 has completed in adults with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASP1941

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED